首页 | 本学科首页   官方微博 | 高级检索  
     


Medication-taking behavior in hypertensive patients with a single-tablet,fixed-dose combination in Japan
Authors:Ikuo Saito  Toshio Kushiro  Yasuyuki Matsushita  Yuki Sato  Kei Sagawa  Yuko Tanaka
Affiliation:1. Keio University Health Center, Kanagawa, Japan, saitoikuokeiouniv@gmail.com;3. The Life Planning Center Foundation, Tokyo, Japan,;4. Daiichi Sankyo Co., Ltd, Tokyo, Japan, and
Abstract:Non-persistence rate (defined as not remaining on treatment) in patients taking a renin angiotensin system inhibitor plus calcium channel blocker was studied in three integrated 12-weeks surveys by matching separate drug combination therapy (CT) and fixed-dose combination (FDC). We also investigated medication adherence measured by proportion of days covered by using a claims database. The non-persistence rate was significantly lower in FDC than CT (p?=?0.0074). In the database study, the medication adherence was higher in FDC than CT for 3, 6, and 12 months (all p?
Keywords:Azelnidipine  fixed-dose combination  medication-taking behavior  olmesartan  Rezaltas
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号